Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ
OPALKA, B, WANDL, U. B, BECHER, R, KLOBE, O, NAGEL-HIEMKE, M, MORITZ, T, BEER, U, SEEBER, S, NIEDERLE, N
Published in Blood (01.11.1991)
Get full text
Published in Blood (01.11.1991)
Journal Article
Minimal Residual Disease in Patients With Chronic Myelogenous Leukemia Undergoing Long-term Treatment With Recombinant Interferon a-2b Alone or in Combination With Interferon γ
Opalka, Bertram, Wandl, Ursula Brigitte, Becher, Reinhard, Kloke, Otto, Nagel-Hiemke, Marianne, Moritz, Thomas, Beer, Ulrike, Seeber, Siegfried, Niederle, Norbert
Published in Blood (01.11.1991)
Published in Blood (01.11.1991)
Get full text
Journal Article